LCB Trademark

Trademark Overview


On Tuesday, December 24, 2024, a trademark application was filed for LCB with the United States Patent and Trademark Office. The USPTO has given the LCB trademark a serial number of 98921341. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, July 9, 2025. This trademark is owned by LigaChem Biosciences Inc.. The LCB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug development; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and pharmaceutical research services; research in the field of medical preparations; medical research laboratory services; medicine research; providing PAAS (platform as a service) featuring computer software used to conduct research and development in the field of pharmac...
lcb

General Information


Serial Number98921341
Word MarkLCB
Filing DateTuesday, December 24, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, July 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized letters "LCB" in the color brown.
Pseudo MarkLIGACHEM BIOSCIENCES
Indication of Colors claimedThe color(s) brown is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug development; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and pharmaceutical research services; research in the field of medical preparations; medical research laboratory services; medicine research; providing PAAS (platform as a service) featuring computer software used to conduct research and development in the field of pharmaceuticals, biotechnology and drugs; laboratory research services relating to pharmaceuticals; research of medical products; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical research and analysis

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 24, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLigaChem Biosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressYuseong-gu, Daejeon 34002
KR

Trademark Events


Event DateEvent Description
Tuesday, December 24, 2024NEW APPLICATION ENTERED
Tuesday, June 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 10, 2025ASSIGNED TO EXAMINER
Wednesday, July 9, 2025NON-FINAL ACTION WRITTEN
Wednesday, July 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 9, 2025NON-FINAL ACTION E-MAILED